NCT03898466
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Asthma Research Lab University of Saskatchewan Room 346 Ellis Hall Saskatoon, Saskatchewan, Canada
Clinical trial condition
Asthma
Explore clinical trials studying Asthma. Study availability and eligibility vary by location and protocol.
2,962 public trials
170 recruiting studies
Asthma trial results
Completed
Leukocyte Function in Asthma and COPD
NCT00147069
- Conditions
- Asthma, Bronchial Diseases, Bronchitis, +18 more
- Locations
-
- Royal Brompton Hospital/NHLI Imperial College London London, United Kingdom
Completed
Asthma and Obstructive Sleep Apnea (OSA)
NCT01026298
- Conditions
- Apnea, Asthma, Bronchial Diseases, +15 more
- Locations
-
- Univeristy of Wisconsin Hospital and Clinics Madison, Wisconsin, United States
Completed
Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Subcutaneously in Children
NCT02377427
- Conditions
- Asthma, Bronchial Diseases, Eosinophilia, +12 more
- Locations
-
- GSK Investigational Site San Diego, California, United States
- GSK Investigational Site Oklahoma City, Oklahoma, United States
- GSK Investigational Site Medford, Oregon, United States
- GSK Investigational Site Madison, Wisconsin, United States
NCT02660853
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Biomedical research Unit, Royal Brompton Hospital, Sydney Street London, United Kingdom
NCT03014674
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site Baltimore, Maryland, United States
- GSK Investigational Site Berlin, Germany
- GSK Investigational Site Harrow, Middlesex, United Kingdom
Completed
A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects
NCT02135692
- Conditions
- Asthma, Bronchial Diseases, Eosinophilia, +12 more
- Locations
-
- GSK Investigational Site Newport Beach, California, United States
- GSK Investigational Site Riverside, California, United States
- GSK Investigational Site Rolling Hills Estates, California, United States
- GSK Investigational Site Denver, Colorado, United States
Completed
Clinical Endpoint Bioequivalence Study of Fluticasone Propionate & Salmeterol Xinafoate (100μg/50μg)
NCT03535870
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- West-Ward Research Site #1 Las Vegas, Nevada, United States
NCT02495168
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Site 100 Surprise, Arizona, United States
- Site 101 Huntington Beach, California, United States
- 111 San Jose, California, United States
- 114 Centennial, Colorado, United States
NCT03188120
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Nippon Boehringer Ingelheim Co., Ltd Tokyo, Japan